Selling and Marketing Expense in USD of ReShape Lifesciences Inc. from 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
ReShape Lifesciences Inc. quarterly/annual Selling and Marketing Expense history and change rate from 2023 to Q2 2025.
  • ReShape Lifesciences Inc. Selling and Marketing Expense for the quarter ending June 30, 2025 was $583K, a 13% decline year-over-year.
  • ReShape Lifesciences Inc. annual Selling and Marketing Expense for 2024 was $2.99M, a 60.4% decline from 2023.
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)

ReShape Lifesciences Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $583K -$87K -13% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $529K -$490K -48.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-20
Q2 2024 $670K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $1.02M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-20

ReShape Lifesciences Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.99M -$4.56M -60.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-04
2023 $7.55M Jan 1, 2023 Dec 31, 2023 10-K 2025-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.